Using Stem Cells to treat Diseases

Cord blood stem cells has been extensively  used for therapies as compared to any other sources of stem cells due to its ready availability and nascent  nature which provides better results post transplant therapy.Apart from this it require the lesser matching (HLA matching) for a therapy using cord blood stem cells as compared to other sources of haemopoetic stem cells it minimises the risk associated with the transplant and making it the best option available for the therapist to use.

Around 25 years ago, the first human transplant using umbilical cord blood stem cells was performed.At the time, treatment of only one disease was possible by using cord blood stem cells.Today, cord blood stem cells can be used in the treatment of nearly 80 diseases and the list continues to develop.

Cord blood stem cells have proven track records on treatment of diseases like Thalassemia, Leukemia, Anaemia, Cerebral Palsy, Diabetes and various blood disorders, bone marrow syndromes, cancers, hemoglobinopathies, Immunodeficiencies, metabolic disorders.

Further more than 300 diseases and conditions are in research progressing towards positive results.

Reference : http://www.healthyhearing.com/report/51792-Study-uses-cord-blood-stem-cells-in-hearing-loss-treatment

New medical technology may well use these cells to  cardiac tissue, repair damage due to stroke or spinal cord injuries and reverse the effects of such diseases as multiple sclerosis or parkinson's.While the research is still in its early stages, the possibilities are extremely promising.And, banking your child's stem cells increases access to any of these technologies in the future.

History of Cord Blood and Transplantation

Details of how stem cells came into existence :

1974	First reports on the presence of stem/progenitor cells in human cord blood.
1983	Dr. Hal Broxmeyer and colleagues are the first to propose the concept of using umbilical cord blood as an alternative source of stem cells to bone marrow for transplant. Dr. Broxmeyer and colleagues create the first "proof of principle" cord blood bank.
1988	The first successful cord blood transplant in the world is performed, by Dr. Eliane Gluckman of St. Louis Hospital, Paris, France on a five-year-old boy, Matthew Farrow, suffering from Fanconi’s Anemia (a blood disorder). The cord blood is collected at Matthew’s sister’s birth and is stored by Dr. Broxmeyer. Matthew’s U.S. physician is Dr. Joanne Kurtzberg.
1989	Dr. Broxmeyer publishes seminal paper in the Proceedings of the National Academy of Sciences that shows that cord blood has similar attributes as bone marrow, contains an enriched source of stem/progenitor cells, and suggests cord blood as a possible alternative source to bone marrow in transplantation.
1989	Dr. Gluckman publishes report of the first successful cord blood transplant in the New England Journal of Medicine.
1990	World's first cord blood transplant for the treatment of leukemia is performed by Dr. John Wagner at the University of Minnesota.
1992	The National Institutes of Health's (NIH) Blood Disease Program at the National Heart, Lung and Blood Institute, under the direction of Dr. Alan Levine, initiates the first federally funded cord blood banking program with Dr. Pablo Rubinstein at the New York Blood Center.
1993	The world's first unrelated cord blood transplant is performed by Dr. Kurtzberg at Duke University Medical Center.
1996	Dr. Kurtzberg publishes the results of her first 25 cord blood transplant patients in the New England Journal of Medicine.
1996	The first FDA approved study with cord blood is sponsored by the National Institutes of Health / National Heart Lung and Blood Institute. The principal investigator of the Cord Blood Transplantation Study (COBLT) is Dr. Kurtzberg.
1997	Stephen Sprague, who is diagnosed with chronic myelogenous leukemia, becomes one of the early adult patients to be cured with a cord blood transplant.
1997	A study is published by Dr. Gluckman in the New England Journal of Medicine reviewing survival rates of patients receiving cord blood transplants and comparing results of related and unrelated transplants.
1998	Keone Penn becomes the first person in the world with sickle cell disease to be successfully treated with a cord blood transplant. The transplant is performed at Emory University Department of Pediatrics.
1998	Dr. Rubinstein of the New York Blood Center and Dr. Kurtzberg publish a landmark analysis of the first 562 cord blood transplant patients in the New England Journal of Medicine. The analysis concluded that cord blood is a useful source of allogeneic hematopoietic stem cells for bone marrow reconstitution for patients with leukemia.
2001	A study is published in the New England Journal of Medicine by Dr. Mary Laughlin that indicates that cord blood is a suitable alternative to bone marrow for treatment of adults with diseases treatable with a stem cell transplant. Drs. Wagner and Kurtzberg are two of the investigators in this study.
2003	Dr. Broxmeyer publishes a report in the Proceedings of the National Academy of Sciences of cord blood cryogenically stored from 1985 to be viable after 15 years.
2003	A U.S. Food and Drug Administration Advisory Panel is created to consider developing guidelines for licensure of cord blood banking and transplantation.
2004	The U.S. Institute of Medicine begins a year-long study to make recommendations for a national cord blood program.
2004	Illinois becomes first state to enact legislation supportive of cord blood banking.
2004- 2005	Researchers confirm that pluripotent stem cells are present in cord blood thus indicating the possible use of cord blood for the treatment of diseases other than those of blood origin.
2005	It is estimated that more than 6,000 cord blood transplants have been performed worldwide.
2005	The United States Congress passes the Stem Cell Therapeutic and Research Act of 2005. The legislation provides funding for qualified cord blood banks to create a national cord blood inventory.
2005	Dr. Kurtzberg and colleagues report success with transplanting children with inherited metabolic disorders with cord blood.  One of their studies, published in the New England Journal of Medicine, concluded that cord blood transplantation favorably altered the natural history of infantile Krabbe disease, a metabolic disorder, in newborns if performed prior to onset of symptoms.
2006	Research by Dr. Wagner and colleagues at the University of Minnesota is published in Current Opinion in Immunology showing success with double cord blood transplants. This breakthrough showed that two partially matched cord blood units could be safely used to treat larger patients for whom a single unit was not adequate.
2006	It is estimated that 7,000-8,000 cord blood transplants have been performed worldwide.
2007	A study by researchers at the University of Florida is presented at the American Diabetes Association annual meeting showing lower A1Cs, lower average insulin requirements, and possible preservation of C-peptide in children with recent onset of Type 1 Diabetes when infused with their own cord blood.
2008	The results of the Cord Blood Transplantation Study (COBLT) are published by Dr. Kurtzberg in Blood, The Journal of the American Society of Hematology.  The results indicated that unrelated donor cord blood transplantation, with partially HLA-mismatched units, can cure many children with leukemias.
2008	It is estimated that more than 12,000 cord blood stem cell transplants have been performed worldwide. Cord blood is being used in the treatment of over 70 life-threatening diseases.
2008	A report is published by J.J Nietfeld in Biology of Blood and Marrow Transplantation of comprehensive estimates of the odds of a person in the U.S. receiving a hematopoietic stem cell transplant (utilizing cord blood stem cells, bone marrow stem cells or peripheral blood stem cells). The study estimated the odds of receiving one's own cells for transplant at approximately 1 in 400.
2009	The FDA releases guidance for the cord blood banking industry.
2009	By now, cord blood legislation has been enacted in more than 20 states.
2010	It is estimated that more than 24,000 cord blood transplants have been performed worldwide.
2011	The FDA decides that cord blood will be the first human cellular and tissue based product in the U.S. to be licensed.
2011	It is estimated that more than 30,000 cord blood transplants have been performed worldwide.

Reference : http://cordbloodbank.corduse.com/why-choose-cord-use-family-cord-blood-bank-cord-use-team-and-the-history-of-cord-blood.php

Umbilical Cord Blood

Umbilical Cord

Umbilical cord is a pipe like structure which connects baby and mother and helps in the transmission of nutrition to baby during the nine months of gestation period.

Umbilical Cord Blood

The blood which flows inside the umbilical cord is known as the umbilical cord blood and consist of large amount of stems cells which are undifferentiated in nature and are responsible for the development of baby during the gestation period.

Usually this Umbilical cord and the blood are discarded by the doctors at the time of delivery of the baby or else kept by the family members who believe in superstitions and old rituals. But apart from that as this blood which we thought of as waste is a rich source of stem cells and now a days is being preserved and used by many people for the treatment of various kind of life threatening  diseases ,cure of which was not possible in the past and there are many more disease on which the research is going on.

Umbilical cord blood is considered equally important as embryonic stem cells and plays very efficient role.Previously cells from the bone marrow were being used for the treatment but nowadays umbilical cord blood stem cells prevails.